• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Coronary artery calcium may indicate risk of cardiovascular disease

bys25qthea
November 20, 2013
in Cardiology, Chronic Disease
Reading Time: 3 mins read
Remote ischemic preconditioning reduced myocardial injury in CABG patients
Share on FacebookShare on Twitter

Image: PD 

1. This study found that coronary artery calcium density was inversely related to risk of coronary heart disease (myocardial infarction, resuscitated cardiac arrest, or coronary heart disease death) and cardiovascular disease (hard cardiovascular disease, stroke, stroke death). 

2. The addition of coronary artery calcium density in a risk scoring system resulted in significantly improved risk prediction. 

Evidence Rating Level: 2 (Good)           

Study Rundown: Computed tomography (CT) scanning can be used to assess coronary artery calcium. The Agatston score is the method currently used to score the amount of calcium in the coronary arteries, and this metric has been shown to predict cardiovascular disease.  This score, however, does not account for the density of calcium in atherosclerotic plaques even though it is hypothesized that higher densities are associated with lower cardiovascular risk.  This study followed 3,394 male and female participants from the Multi-Ethnic Study of Atherosclerosis (MESA) for a median of 7.6 years.  The natural logarithm of coronary artery calcium volume had an association with incident coronary heart disease and cardiovascular disease.  The coronary artery calcium density, however, was inversely correlated with coronary heart disease and cardiovascular disease risk.  The authors subsequently found that coronary artery calcium density improved risk prediction using a risk prediction model.

Major strengths of this study include the large sample size and diversity of the population studied.  Limitations of the study include a relatively short follow up time of 7.6 years and the fact that outcomes like angina and need for cardiac revascularization were not included in the model.  While this study identifies an important relationship, further studies will be required before coronary artery calcium density can be incorporated into risk prediction models used in clinical practice.

RELATED REPORTS

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

Clopidogrel monotherapy is superior to aspirin for secondary prevention in coronary artery disease

Click to read the study in JAMA

Relevant Reading: Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals

In-Depth [prospective cohort study]: This study followed 3,394 men and women from the Multi-Ethnic Study of Atherosclerosis (MESA) for a median of 7.6 years after a CT scan to assess coronary artery calcium for one of two types of cardiac endpoints: coronary heart disease (myocardial infarction, cardiac arrest with resuscitation, or coronary heart disease death) and cardiovascular disease (hard cardiovascular disease, stroke, or stroke death. The natural logarithm of coronary artery calcium was independently associated with an increased risk of coronary heart disease (HR 1.81, 95% CI 1.47-2.23 per standard deviation increase) and an increased risk of cardiovascular disease (HR 1.68, 95% CI 1.42-1.98 per standard deviation increas. Area under the receiver operating curve analysis also showed that the addition of coronary artery calcium density to risk prediction models for coronary heart disease and cardiovascular disease resulted in significant improvement.

By Jeffrey Cohen and Rif Rahman

More from this author: Most physicians point to others to control healthcare costs, QRS morphology and duration associated with cardiac resynchronization outcomes, Repeat bone mineral density testing may not improve prediction of fracture outcomes, Risk-reduction counseling with HIV testing may not decrease rates of sexually transmitted infections, Autoantibodies may precede symptom onset in Sjögren’s Syndrome

©2012-2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: Coronary artery diseasemyocardial infarction
Previous Post

Home Calculator may predict likelihood of home discharge after surgery

Next Post

Polio outbreak in China halted: Case report

RelatedReports

Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Cardiology

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

January 12, 2026
Lariat device for left atrial appendage exclusion associated with adverse events
Cardiology

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

January 13, 2026
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Clopidogrel monotherapy is superior to aspirin for secondary prevention in coronary artery disease

October 30, 2025
β-blockers linked to improved survival in preserved ejection fraction heart failure
Cardiology

Multidomain rehabilitation after myocardial infarction improves outcomes in older adults

October 15, 2025
Next Post
Polio outbreak in China halted: Case report

Polio outbreak in China halted: Case report

Nut consumption associated with lower overall mortality

Nut consumption associated with lower overall mortality

Stem cell enrichment of fat grafts ineffective in breast augmentation

Stem cell enrichment of fat grafts ineffective in breast augmentation

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
  • Real-time AI guidance enters live brain tumor surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.